Search results

From Self-sufficiency
Jump to: navigation, search

Page title matches

  • ...rom 1967 to 1972 it was known as ''FDA Papers'' before changing title to ''FDA Consumer'' with v.6 #6 (July/August 1972). ...depository library|depository libraries]] which selected to receive it. ''FDA Consumer'' ceased publication with v.41 #2 (March-April 2007), though exist
    861 bytes (116 words) - 18:09, 9 December 2011

Page text matches

  • ...ramps]]. This practice is now considered dubious by the FDA<ref>http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders ...sumers About Off-Label Use of Quinine to Treat Leg Cramps | url=http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2006/ucm108799.htm | accessdate=
    27 KB (3,844 words) - 16:41, 27 September 2010
  • 1. "At the time this study was conceived, no formal FDA guidelines for neurotoxicity testing existed. In contrast, first-tier neuro The FDA "approval" process in 1970 did not require safety testing for neurotoxicity
    13 KB (1,807 words) - 16:41, 27 September 2010
  • ...(an excess of aluminium in the body) in select patients although it is not FDA approved for this use.
    5 KB (714 words) - 20:14, 21 September 2010
  • | UNII_Ref = {{fdacite|correct|FDA}} ...FDA Approves Narcan Nasal Spray|url = http://www.jems.com/articles/2015/11/fda-approves-narcan-nasal-spray.html|website = www.jems.com|accessdate = 2015-1
    33 KB (4,541 words) - 10:57, 17 June 2016
  • In the United States, the [[Food and Drug Administration|FDA]]-approved indications for carbamazepine use are [[epilepsy]] (including [[ ...for Drugs, Biologics, Medical Devices, and Dietary Supplements |publisher=FDA}}</ref> In Europeans a large proportion of sensitivity is associated with [
    16 KB (2,164 words) - 16:42, 27 September 2010
  • ...ov/fdac/features/2007/107_drug.html |date=January-February 2007 |publisher=FDA Consumer magazine |accessdate=2007-09-27}}</ref>
    20 KB (2,657 words) - 16:42, 27 September 2010
  • ...ilization]], although it has never been approved for those purposes by the FDA. [[Jack Dreyfus]], founder of the [[Dreyfus Fund]], became a major proponen ...at the FDA has identified a potential safety issue, but does not mean that FDA has identified a causal relationship between the drug and the listed risk.
    12 KB (1,686 words) - 16:42, 27 September 2010
  • ...d Drug Administration (United States)|U.S. Food and Drug Administration]] (FDA) has not approved albendazole for this indication. It is marketed by [[Glax
    10 KB (1,261 words) - 13:28, 4 September 2010
  • ...ef>{{cite web | url = http://www.medscape.com/viewarticle/548709 | title = FDA Approvals: Ziana, Kadian, Polyphenon E | last = Waknine | first = Yael | da
    25 KB (3,261 words) - 14:17, 11 September 2010
  • ...d Drug Administration (United States)|U.S. Food and Drug Administration]] (FDA) approval in 1967, becoming Pfizer's first once-a-day broad-spectrum antibi
    20 KB (2,578 words) - 16:43, 27 September 2010
  • ...d Drug Administration (United States)|U.S. Food and Drug Administration]] (FDA) approved) *[[Crohn's disease]] with colonic or perianal involvement (non-FDA approved){{ndash}} believed to be more effective in combination with [[cipr
    19 KB (2,528 words) - 16:43, 27 September 2010
  • ...of the Council Regulation 2377/90. The [[Food and Drug Administration]] (FDA) of the United States has prohibited [[furaltadone]] since February 1985 an
    12 KB (1,576 words) - 16:43, 27 September 2010
  • ...nd's being fast-tracked for approval by the [[Food and Drug Administration|FDA]] in 1958. Eli Lilly first marketed vancomycin hydrochloride under the trad ...rmacare]] in Australia. The [[patent]] expired in the early 1980s, but the FDA has not authorized the sale of any generic versions in the USA.
    31 KB (4,198 words) - 16:43, 27 September 2010
  • ...government named Clofazimine an [[orphan drug]] in June 1986. Geigy gained FDA approval for the drug in December 1986. ...its immunosuppressive activity even before it was approved for leprosy by FDA. It was first reported to be effective in treating chronic discoid lupus er
    12 KB (1,651 words) - 16:43, 27 September 2010
  • Fluconazole/Diflucan is in the FDA pregnancy category C. <br />This means that it is not known whether it will
    11 KB (1,533 words) - 16:44, 27 September 2010
  • FDA-approved dosing of potassium iodide for this purpose with iobenguane, is as ...s/Guidance%20for%20use%20of%20KI%20for%20nuclear%20emergency%20USG.pdf] US FDA, "Potassium Iodide as a Thyroid Blocking Agent in Radiation Emergencies," U
    23 KB (3,281 words) - 16:44, 27 September 2010
  • Abacavir was approved by the [[Food and Drug Administration]] (FDA) on December 18, 1998 and is thus the fifteenth approved antiretroviral dru A new FDA alert concerning abacavir and abacavir containing medications
    8 KB (1,124 words) - 16:44, 27 September 2010
  • ...ates by the [[Food and Drug Administration]] (FDA) on October 9, 1991. Its FDA approval helped bring down the price of [[zidovudine]] (AZT), the initial a ...oul-tasting and the buffering compound would cause diarrhea. Although the FDA had not approved the original formulation for once-a-day dosing it was poss
    9 KB (1,239 words) - 16:44, 27 September 2010
  • ...d Drug Administration (United States)|U.S. Food and Drug Administration]] (FDA) on July 12, 2006 under the brand name '''Atripla'''. It was approved by the FDA July 2, 2003. It is very similar to [[3TC]] and cross-resistance between th
    5 KB (667 words) - 16:44, 27 September 2010
  • Lamivudine was approved by the [[Food and Drug Administration]] (FDA) on November 17, 1995 for use with [[zidovudine]] (AZT) and again in 2002 a
    9 KB (1,248 words) - 16:44, 27 September 2010
  • ...um]]. Stavudine was approved by the U.S. [[Food and Drug Administration]] (FDA) in June 24, 1994 for adults and in September 6, 1996 for pediatric use and
    4 KB (574 words) - 16:44, 27 September 2010
  • ...ination of tenofovir, emtricitabine and [[efavirenz]], was approved by the FDA on 12 July 2006 and is now available, providing a single daily dose for the ...nline.wsj.com/article/SB121849463154631469.html?mod=us_business_whats_news FDA Clears Viread for Hepatitis B]</ref>.
    6 KB (871 words) - 16:45, 27 September 2010
  • ...d Drug Administration (United States)|U.S. Food and Drug Administration]] (FDA) in July 2006 under the brand name [[Atripla]], provides HAART in a single Efavirenz was approved by the FDA on September 21, 1998, making it the 14th approved antiretroviral drug.
    10 KB (1,441 words) - 16:45, 27 September 2010
  • ...d Drug Administration (United States)|U.S. Food and Drug Administration]] (FDA). It was approved June 21, 1996 for adults and September 11, 1998 for child ...could cause severe liver damage, including liver failure.<ref>[http://www.fda.gov/medwatch/safety/2000/viramune.htm Viramune (nevirapine) letter (Novembe
    15 KB (2,090 words) - 16:45, 27 September 2010
  • The [[Food and Drug Administration]] (FDA) approved indinavir March 13, 1996, making it the eighth approved antiretro
    3 KB (320 words) - 15:07, 6 July 2010
  • Lopinavir/ritonavir was approved by the [[US]] [[Food and Drug Administration|FDA]] on 15 September 2000, and in Europe in April 2001. Its patent will expire ...e Kaletra (lopinavir/ritonavir) with caution <ref name="SafetyLabel200904">FDA Issues Safety Labeling Changes for Kaletra, 2009-04-10, [http://www.medscap
    8 KB (1,109 words) - 16:45, 27 September 2010
  • ...nventions| date=2004-06-03}}.</ref> The [[Food and Drug Administration]] (FDA) approved ritonavir on March 1, 1996, making it the seventh approved antire
    9 KB (1,233 words) - 15:07, 6 July 2010
  • ...$528 in Africa. It was approved by the U.S. [[Food and Drug Administration|FDA]] on July 12, 2006. In the UK, the drug cost to the NHS is {{GB£}}620 per *[http://thebody.com/fda/atripla.html Atripla] article on The Body, an HIV reference site
    6 KB (773 words) - 16:45, 27 September 2010
  • ...nd sixth antiretroviral) approved by the [[Food and Drug Administration]] (FDA). It was approved on December 6, 1995, as Invirase, a poorly-absorbed hard
    5 KB (717 words) - 15:07, 6 July 2010
  • ...icense fees to [[Valeant Pharmaceuticals International]]. The only present FDA-approved indication for these products is in conjunction with interferon ag ...ials against experimental influenza infection were mixed, however, and the FDA ultimately did not approve this indication for ribavirin use in humans, the
    23 KB (3,222 words) - 16:45, 27 September 2010
  • ...Migraine Pain | publisher = [[U.S. Food and Drug Administration]] | work = FDA Consumer magazine | year = 1998}}</ref> ...children. As a result of some lingering concerns about nitrite safety, the FDA and the USDA commissioned a comprehensive review of sodium nitrite's role a
    21 KB (3,046 words) - 16:45, 27 September 2010
  • ...pine has not been officially indicated for either of these purposes by the FDA, it has been used by physicians for these purposes.<ref>[http://www.eperc.m
    16 KB (2,198 words) - 16:46, 27 September 2010
  • The U.S. [[Food and Drug Administration|FDA]] assigned PAS to [[pregnancy category]] C, indicating that it is not known
    7 KB (879 words) - 16:46, 27 September 2010
  • ...States)|Food and Drug Administration]] (FDA) in 1987. Ciprofloxacin has 12 FDA-approved human uses and other veterinary uses, but it is often used for non ...Bayer introduced ciprofloxacin in 1987 and was later approved by the U.S. FDA on 22 October 22 1987 for use in the United States to treat specific bacter
    88 KB (11,930 words) - 16:46, 27 September 2010
  • ...d Drug Administration (United States)|U.S. Food and Drug Administration]] (FDA) approved AzaSite, an ophthalmic formulation of azithromycin, for the treat
    15 KB (2,008 words) - 16:46, 27 September 2010
  • ...for download on [http://www.fda.gov/Drugs/InformationOnDrugs/ucm079750.htm FDA website].</ref> [[generic drug|Generic]] formulations are now available in ...amet.html |archiveurl=http://web.archive.org/web/20071014014507/http://www.fda.gov/oc/qanda/PaxilandAvandamet.html |archivedate=14 October 2007}}</ref> Th
    66 KB (8,976 words) - 16:47, 27 September 2010
  • Valproic acid is also FDA approved for the treatment of [[manic episodes]] associated with [[bipolar | title = FDA Issues Approvable Letter For Stavzor Delayed Release Valproic Acid Capsules
    25 KB (3,328 words) - 16:47, 27 September 2010
  • ...presented a new drug request to the [[U.S. Food and Drug Administration]] (FDA) for fluoxetine.<ref>{{Cite book| last =Breggin| first =Peter R.| coauthors ...ug Administration | month= April | year= 2007| url =http://www.accessdata.fda.gov/scripts/cder/ob/docs/obdetail.cfm?Appl_No=018936&TABLE1=OB_Rx | accessd
    52 KB (7,168 words) - 16:47, 27 September 2010
  • ...l adverse effects (approved by the [[U.S. Food and Drug Administration]], "FDA") are deemed insufficient by state courts. ...which reduces risk of surrounding muscle and tissue damage <ref>http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders
    10 KB (1,347 words) - 21:10, 12 September 2010
  • ...ctive therapy" in certain poisoning cases.<ref>{{cite web| url =http://www.fda.gov/Drugs/EmergencyPreparedness/BioterrorismandDrugPreparedness/ucm130337.h *[http://www.fda.gov/cder/drug/infopage/prussian_blue/Q&A.htm The FDA's page on prussian blue]
    20 KB (3,004 words) - 16:47, 27 September 2010
  • ...ssion]], which ultimately leads to cell [[lysis]]. Ampicillin has received FDA approval for its action of mechanism.
    7 KB (881 words) - 16:47, 27 September 2010
  • ...Administration. [http://www.fda.gov/bbs/topics/ANSWERS/2004/ANS01329.html "FDA Strengthens Labels of Two Specific Types of Antibiotics to Ensure Proper Us
    4 KB (483 words) - 16:48, 27 September 2010
  • ...http://www.merck.com/newsroom/news-release-archive/product/2009_1201a.html FDA Approves Zegerid OTC for Over-the-Counter Treatment of Frequent Heartburn]. ...1995. URL: [http://www.fda.gov/fdac/features/695_prescrip.html http://www.fda.gov/fdac/features/695_prescrip.html]. Accessed on: June 11, 2006.</ref> Un
    17 KB (2,299 words) - 09:15, 5 September 2010
  • On April 25, 2008 the FDA issued a press release<ref>http://www.fda.gov/oc/po/firmrecalls/actavis04_08.html</ref> alerting the public to a Clas On March 31, 2009 the FDA announced another generic digoxin pill recall by posting this company press
    19 KB (2,738 words) - 16:48, 27 September 2010
  • ...ks. The highest approved dose of simvastatin is 80&nbsp;mg.<ref>http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders ...name="urlInformation on Simvastatin/Amiodarone">{{cite web |url=http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders
    14 KB (1,967 words) - 16:48, 27 September 2010
  • ...lymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=11119 |title=FDA drug information, acetazolamide capsule, extended release | author= | publi
    12 KB (1,686 words) - 16:48, 27 September 2010
  • Under FDA rules, this drug, like many others, excludes eligibility for blood donation
    11 KB (1,410 words) - 16:49, 27 September 2010
  • ...d Drug Administration (United States)|U.S. Food and Drug Administration]] (FDA) in April 2005 mandated that all (including salbutamol) inhalers containing ...re patented. An industry consortium was formed to spread the costs of the FDA safety studies to get propellants such as 134a and 227 approved.<ref>[http:
    15 KB (2,005 words) - 16:49, 27 September 2010
  • ...ww.fda.gov/newsevents/newsroom/pressannouncements/ucm149533.htm]</ref> The FDA only approves metoclopramide for 4-12 week short term treatment. ...=U.S. Food and Drug Administration |date=February 26, 2009 |url=http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm149533.htm |accessdate=2009-0
    11 KB (1,453 words) - 16:49, 27 September 2010
  • .../www.rxlist.com/cgi/generic/ibup.htm Motrin (Ibuprofen) drug description - FDA approved labeling for prescription drugs and medications at RxList<!-- Bot ...47.html |title=FDA Approves Caldolor: Cumberland Pharmaceuticals Announces FDA Approval of Caldolor |date=June 11, 2009 |publisher=Drugs.com |accessdate=2
    29 KB (3,955 words) - 22:17, 21 September 2010
  • ...e assembly of [[Boyle's machine]]s. Because India's Food & Drug Authority (FDA-India) rules state that transferring a drug from one container to another (
    61 KB (8,728 words) - 16:50, 27 September 2010
  • ...hough this use is in decline.<ref>{{cite web|author = FDA|url = http://www.fda.gov/Cber/vaccine/thimerosal.htm|title = Thimerosal in Vaccines|accessdate=O ...tivated influenza vaccine.<ref>{{cite web |date=2007-09-06 |url=http://www.fda.gov/cber/vaccine/thimerosal.htm |accessdate=2007-10-01 |title= Thimerosal i
    69 KB (10,077 words) - 21:35, 20 September 2010
  • ...uld later prove useful. Zidovudine (AZT) was approved for marketing by the FDA on March 20, 1987.<ref name="Cimons">{{cite news | last = Cimons | first = ...) approved the drug (via the then-new [[FDA Fast Track Development Program|FDA accelerated approval system]]) for use against HIV, AIDS, and ''AIDS Relate
    21 KB (3,049 words) - 16:51, 27 September 2010
  • ...ower than 2.5&nbsp;grams per day.<ref name="2009_FDA_support">"[http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafet ...[http://www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/ucm165107.htm "FDA: Drug Safety & Availability - Acetaminophen Information"]</ref>
    54 KB (7,376 words) - 16:52, 27 September 2010
  • ...Circuit|U.S. Court of Appeals for the Tenth Circuit]] in Denver upheld the FDA's final rule declaring all dietary supplements containing ephedrine alkaloi
    21 KB (2,906 words) - 16:51, 27 September 2010
  • ...as approved by the American [[Food and Drug Administration (United States)|FDA]] in January 2008. ...title=MiddleBrook Pharmaceuticals Launches MOXATAG(TM), the First and Only FDA-Approved Once-Daily Amoxicillin |year=2009 | month=March| url=http://www.mi
    11 KB (1,413 words) - 16:52, 27 September 2010
  • | work = FDA Poisonous Plant Database | url = http://vm.cfsan.fda.gov/~djw/pltx.cgi?QUERY=tephrosia
    3 KB (345 words) - 12:27, 7 July 2010
  • ...(United States)|U.S. Food and Drug Administration]] (FDA).<ref>[http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/EnforcementActi
    19 KB (2,832 words) - 12:27, 7 July 2010
  • ...is no antidote. Despite its [[toxicity]], colchicine is approved by the US FDA for the treatment of [[gout]] and [[Familial Mediterranean Fever]] and is a
    4 KB (471 words) - 12:27, 7 July 2010
  • ...ov/ohrms/dockets/dailys/03/jul03/070303/81N-0033P_emc-000001.txt Letter to FDA], Professor George T. Gallagher, [[Boston University]] [[Goldman School of | url = http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/EnforcementActivitiesbyFD
    14 KB (2,005 words) - 12:27, 7 July 2010
  • * [http://www.fda.gov/bbs/topics/NEWS/2003/NEW00941.html FDA Issues Advisory on Star Anise "Teas"]
    3 KB (449 words) - 12:28, 7 July 2010
  • ...d in the United States by the [[United States Food and Drug Administration|FDA]], that combines natural belladonna alkaloids in a specific, fixed ratio wi
    24 KB (3,421 words) - 12:28, 7 July 2010
  • ...with the use of temazepam. According to the [[Food and Drug Administration|FDA]], temazepam had an incidence of euphoria of 1.5%, much more rarely reporte
    45 KB (6,129 words) - 22:16, 19 September 2010
  • ...ght to [[chelate]] the bivalents [[calcium]] and [[magnesium]]. It is not FDA approved for human use as an antiarrhythmic agent, and it is not included i
    7 KB (891 words) - 09:44, 20 September 2010
  • It was withdrawn from FDA review by the manufacturer after [[clinical trials#Phase III|phase III clin
    2 KB (250 words) - 09:44, 20 September 2010
  • ...uesting that Solvay Pharmaceuticals provides additional information to the FDA.<ref>{{cite web |url=http://www.drugs.com/nda/pulzium_071213.html |title=Dr
    2 KB (270 words) - 09:44, 20 September 2010
  • ...w.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2006/ucm108644.htm |title=FDA Approves First Generic Pravastatin |accessdate=2008-01-20 |format= |work=}}
    3 KB (359 words) - 09:44, 20 September 2010
  • ...ne, blood circulation, and the liver. It was approved by the United States FDA on 6 March 2007, and for use in Europe on 27 August 2007. Its trade name is
    5 KB (697 words) - 09:44, 20 September 2010
  • ...bination-medicine-comprehensive-846.html |title=Drugs.com, Abbott Receives FDA Approval for Simcor (Niaspan / simvastatin), a Novel Combination Medicine f
    1 KB (165 words) - 09:44, 20 September 2010
  • ...s by [[Acorda Therapeutics]] and will be available in March 2010.<ref name=FDA /><ref>http://www.nationalmssociety.org/news/news-detail/index.aspx?nid=258
    9 KB (1,146 words) - 09:44, 20 September 2010
  • According to the [[National Psoriasis Foundation]] and the FDA, coal tar is a valuable, safe and inexpensive treatment option for millions
    5 KB (781 words) - 10:07, 20 September 2010
  • ...ds and caustics but is not compatible with [[solvents]]. It is supplied in FDA approved food grade. HDPE is naturally translucent and flexible. The additi
    9 KB (1,285 words) - 15:54, 15 April 2013
  • ...familiar with the vocabulary. If you are not experienced with handling the FDA regulations, please be careful to avoid misinterpretations. The FDA considers three different types of food additives:
    5 KB (799 words) - 10:08, 20 September 2010
  • | licence_US = <!-- FDA may use generic name --> The FDA has approved Chemische Fabrik Kreussler & Co.’s Asclera (polidocanol) inj
    3 KB (391 words) - 10:09, 20 September 2010
  • *A biostable, biocompatible coating; FDA approved for various applications
    8 KB (1,048 words) - 10:09, 20 September 2010
  • ...Mesh in Repair of Pelvic Organ Prolapse and Stress Urinary Incontinence], FDA, October 20, 2008</ref>
    25 KB (3,657 words) - 10:10, 20 September 2010
  • ...extraction residues and of the removal of model contaminants according to FDA applying the so called challenge test, which is necessary for the applicati ...less necessary that any user of such processes has to constantly check the FDA-limits for the raw materials manufactured by himself for his process.
    43 KB (6,272 words) - 10:11, 20 September 2010
  • ...lystyrene foodservice products and reached the same conclusion as the U.S. FDA.<ref>[http://www.americanchemistry.com/s_plastics/doc_pfpg.asp?CID=2300&DID
    36 KB (5,017 words) - 10:14, 20 September 2010
  • ...dehyde]] (kills insects), [[ethanol]] and [[methylchloroisothiazolinone]]. FDA standards do not currently require fruit and vegetable product labels to re
    5 KB (621 words) - 10:17, 20 September 2010
  • ...d Drug Administration (United States)|U.S. Food and Drug Administration]] (FDA) in October 2008 for the induction and maintenance of remission in ulcerati
    6 KB (792 words) - 13:12, 20 September 2010
  • ...f>{{cite web|url=http://www.medicalnewstoday.com/articles/167910.php|title=FDA Approves GlaxoSmithKline's Votrient(TM) For Advanced Renal Cell Cancer|publ
    3 KB (324 words) - 13:12, 20 September 2010
  • ...including gentian violet, had been consistently found in the products. The FDA report states: ...achite green, gentian violet and nitrofuran cause cancer? | url=http://www.fda.gov/Food/FoodSafety/Product-SpecificInformation/Seafood/ucm119105.htm#q12 |
    21 KB (3,043 words) - 13:13, 20 September 2010
  • ...ere the substance is also banned for use in aquaculture. In June 2007, the FDA blocked the importation of several varieties of seafood due to continued ma *[http://www.cfsan.fda.gov/~frf/lib4363.html U.S. Food and Drug Administration]
    11 KB (1,647 words) - 13:13, 20 September 2010
  • .../templates/SLV_Page.aspx?id=11592&epslanguage=SV Livsmedelsverket (Swedish FDA)]</ref>. It is similar to [[ephedrine]] <ref name=liv/> and can therefore s ...topamine from "bitter orange" had in effect simply found a loophole in the FDA's April 2004 regulation banning ephedra in those supplements by substitutin
    7 KB (919 words) - 13:14, 20 September 2010
  • ...ersity School of Medicine in 1999 had produced similar results.[http://www.fda.gov/ohrms/dockets/ac/00/backgrd/3647b1_tab19.doc] Reports of cases of hemor ...rom over-the-counter sale.<ref>[http://www.fda.gov/cder/drug/infopage/ppa/ FDA moves PPA from OTC]</ref> Because of its potential use in [[amphetamine]] m
    11 KB (1,420 words) - 13:15, 20 September 2010
  • The [[U.S. Food and Drug Administration]] (FDA) requires all class IIIb and class IV lasers offered in commerce in the US ...d Drug Administration (United States)|U.S. Food and Drug Administration]] (FDA) on laser products imported into the US. The old and revised systems can be
    40 KB (6,222 words) - 21:31, 20 September 2010
  • ...ew Report: [http://uk.reuters.com/article/healthNews/idUKN0524254120070905 FDA to probe popcorn link in man's lung disease].</ref> His lung problems were
    15 KB (2,087 words) - 21:32, 20 September 2010
  • ....<ref>[http://www.cbsnews.com/stories/2006/05/19/health/main1638170.shtml "FDA: Too Much Benzene In Some Drinks"], ''CBS News'', May 19, 2006, retrieved J
    45 KB (6,444 words) - 21:33, 20 September 2010
  • ...hen-the-fda-doesnt-want-to-know/ Popcorn Lung Coming to Your Kitchen? The FDA Doesn’t Want to Know], a blog post at ''thepumphandle.wordpress.com'' ...ew Report: [http://uk.reuters.com/article/healthNews/idUKN0524254120070905 FDA to probe popcorn link in man's lung disease].
    13 KB (1,731 words) - 21:34, 20 September 2010
  • ...on testing can be particularly high where the applications are governed by FDA regulations (e.g. Clinical Laboratory systems). Physicians desire modular u
    57 KB (8,295 words) - 21:37, 20 September 2010
  • ...this practice is controversial due to no scientific plausibility, lack of FDA approval, and its potentially deadly side-effects.<ref>{{cite journal|journ
    13 KB (1,928 words) - 20:14, 21 September 2010
  • ...se | url = http://www.fda.gov/bbs/topics/news/2005/NEW01258.html | title = FDA Approves First Oral Drug for Chronic Iron Overload | date = November 9, 200 ...Drug Administration]] (FDA) in November 2005.<ref name=Choudhry/><ref name=FDA/>
    5 KB (703 words) - 20:15, 21 September 2010
  • The FDA determined that the substance was a drug rather than a supplement and issue | title = FDA warns maker of product used as alternative autism treatment
    5 KB (664 words) - 20:16, 21 September 2010
  • ...otmed.com/news/story/3067/ dotmed.com December 27, 2006] ''Low Level Laser FDA Cleared for the Treatment of Lymphedema''. (accessed 9 Nov 09)</ref>
    24 KB (3,493 words) - 21:25, 21 September 2010
  • ...are not allowed as health statements by regulatory authorities like the [[FDA]]. Among these potential effects are anti-aging consequences such as slowi
    13 KB (1,796 words) - 21:29, 21 September 2010
  • ...y considered appropriate (as evidenced by the range of use approved by the FDA in US) only for “management of severe chronic pain in patients for whom i ...article.cgi?f=/news/archive/2004/12/28/national1642EST0612.DTL&type=health FDA approves new drug for severe pain], a December 2004 [[Associated Press]] ar
    8 KB (1,082 words) - 22:04, 21 September 2010
  • ...d Drug Administration (United States)|U.S. Food and Drug Administration]] (FDA) in 2004 for use as a post-surgical pain reliever. In Europe, it was approv
    876 bytes (114 words) - 22:05, 21 September 2010
  • ...om/pressroom/news_feeds/fdaapprovals/fda_valdecoxib.html "Valdecoxib. U.S. FDA Drug Approval."] Last accessed June 8, 2007.</ref> and was available by pre ...2005, Pfizer withdrew Bextra from the U.S. market on recommendation by the FDA, citing an increased risk of [[myocardial infarction|heart attack]] and [[s
    6 KB (784 words) - 22:05, 21 September 2010
  • ...d Drug Administration (United States)|U.S. Food and Drug Administration]] (FDA)) to treat [[migraine]]s. The mechanism of action is not well understood.
    2 KB (225 words) - 22:06, 21 September 2010
  • ...daches]]. It is also commonly prescribed for migraines although it is not FDA indicated for this use. The usual adult dose is 1-2 tablets every four hou
    3 KB (378 words) - 22:06, 21 September 2010

View (previous 100 | next 100) (20 | 50 | 100 | 250 | 500)